SCHEMBL2829057

SCHEMBL2829057

CNc1ccc(C=Cc2ccc(OCC(CO)CO)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13207855 0.93 APP (0.86) APP
SCHEMBL2832302 0.92 APP (1.00) APP
SCHEMBL12973237 0.81 APP (0.78) APP
SCHEMBL12973266 0.80 APP (0.68) APP
SCHEMBL2831859 0.80 APP (0.83) APP
SCHEMBL13096116 0.79 APP (0.71) APP
SCHEMBL13096119 0.78 APP (0.70) APP
SCHEMBL13096195 0.78 APP (0.64) APP
SCHEMBL14186772 0.77 APP (0.62) APP
SCHEMBL13431717 0.76 APP (0.73) APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858072-B2 Stilbene derivatives and their use for binding and imaging amyloid plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-12-28 — — US disclosed
EP-1838298-A4 STILBENE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES UNIV PENNSYLVANIA (US) 2009-03-04 — — EP disclosed
EP-1838298-A2 STILBENE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES The Trustees of The University of Pennsylvania (US) 2007-10-03 — — EP disclosed
US-20060269474-A1 Stilbene derivatives and their use for binding and imaging amyloid plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2006-11-30 — — US disclosed
WO-2006078384-A2 STILBENE DERIVATIVES AND THEIR USE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2006-07-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060269474-A1 Stilbene derivatives and their use for binding and imaging amyloid plaques APP, APBA1, PSEN1 APP 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback